|
Name |
(+)-aS-alterporriol C
|
Molecular Formula | C32H26O13 | |
IUPAC Name* |
1-(1,5,6,7,8-pentahydroxy-3-methoxy-7-methyl-9,10-dioxo-6,8-dihydro-5H-anthracen-2-yl)-2,8-dihydroxy-6-methoxy-3-methylanthracene-9,10-dione
|
|
SMILES |
COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(-c3c(OC)cc4c(c3O)C(=O)C3=C(C4=O)C(O)C(C)(O)C(O)C3O)c1C2=O
|
|
InChI |
InChI=1S/C32H26O13/c1-9-5-11-17(26(37)16-12(24(11)35)6-10(44-3)7-14(16)33)20(23(9)34)19-15(45-4)8-13-18(27(19)38)28(39)21-22(25(13)36)30(41)32(2,43)31(42)29(21)40/h5-8,29-31,33-34,38,40-43H,1-4H3/t29-,30+,31+,32-/m0/s1
|
|
InChIKey |
PSGFKGASHCTNSI-BVEPWEIPSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 618.55 | ALogp: | 1.1 |
HBD: | 7 | HBA: | 13 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 228.3 | Aromatic Rings: | 6 |
Heavy Atoms: | 45 | QED Weighted: | 0.173 |
Caco-2 Permeability: | -6.439 | MDCK Permeability: | 0.00000531 |
Pgp-inhibitor: | 0.704 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.941 | 20% Bioavailability (F20%): | 0.025 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 92.97% |
Volume Distribution (VD): | 0.295 | Fu: | 8.29% |
CYP1A2-inhibitor: | 0.614 | CYP1A2-substrate: | 0.903 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.054 |
CYP2C9-inhibitor: | 0.366 | CYP2C9-substrate: | 0.083 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.156 |
CYP3A4-inhibitor: | 0.054 | CYP3A4-substrate: | 0.054 |
Clearance (CL): | 2.254 | Half-life (T1/2): | 0.094 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.083 |
Drug-inuced Liver Injury (DILI): | 0.981 | AMES Toxicity: | 0.497 |
Rat Oral Acute Toxicity: | 0.052 | Maximum Recommended Daily Dose: | 0.934 |
Skin Sensitization: | 0.862 | Carcinogencity: | 0.006 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.54 |
Respiratory Toxicity: | 0.089 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002596 | 0.778 | D01XWG | 0.282 | ||||
ENC005390 | 0.778 | D0C9XJ | 0.277 | ||||
ENC000947 | 0.678 | D07VLY | 0.277 | ||||
ENC000911 | 0.678 | D0T5XN | 0.267 | ||||
ENC003207 | 0.571 | D0AZ8C | 0.246 | ||||
ENC003729 | 0.535 | D01UBX | 0.246 | ||||
ENC003770 | 0.535 | D09LBS | 0.245 | ||||
ENC000995 | 0.528 | D0Z2LG | 0.245 | ||||
ENC000783 | 0.525 | D07IPB | 0.240 | ||||
ENC005226 | 0.484 | D0FX2Q | 0.240 |